Evidence tier Source Confirmed · 4 captures on record
What the publisher says
As described on AWS Marketplace.
Deloitte has built a set of 2 AI agents as a part of its Clinical Trial Agent Suite. These form a part of Agent Fleet - a fleet of agents built by Deloitte. The Clinical Trial Agent Suite is designed to address specific needs within patient eligibility verification and clinical trial criteria research. These agents leverage advanced AI technologies to verify patient eligibility, research and summarize trial criteria, and facilitate efficient and accurate identification of relevant trial criteria. They help achieve improved accuracy in patient eligibility verification, reduced recruitment timelines, and increased operational efficiency. This agent(s) will be deployed and configured using AWS Generative AI services by Deloitte.
Highlights
Highlighted by the publisher on AWS Marketplace.
Automates patient eligibility verification and trial criteria research
Improves accuracy and reduces recruitment timelines
Enhances operational efficiency in clinical trial management
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Sources
Linked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.